This is an elective module of the Biomarker Testing Stewardship Certificate program. This online, interactive module focuses on the crucial role of biomarker testing in hematologic malignancies. It emphasizes that the timely and accurate delivery of these test results to clinicians is vital for guiding critical treatment decisions. Participants will gain skills in prioritizing tests, interpreting biomarker results, and optimizing workflows specifically for blood cancers. Participants will learn to align biomarkers with therapies, address challenges, and implement NCCN/ASCO guidelines.
To enroll for free in the full Biomarker Testing Stewardship Certificate program, click here:
Course topics include:
- Biomarkers in hematologic malignancies
- Applying guidelines and best practices for biomarker testing in hematologic malignancies
- Further directions and emerging biomarkers
Target Audience
This activity has been designed to meet the educational needs of pathologists and laboratory professionals.
Learning Objectives
Upon completion of this activity, you will be able to:
- Specify five key types of hematologic malignancies
- Differentiate between specific biomarker types in hematologic malignancies and their roles in diagnosis, prognosis and therapy selection.
- Identify specific biomarker-directed therapies and their applications across hematologic malignancies.
- Integrate current guidelines and best practices into the prioritization and evaluation of biomarker testing for hematologic malignancies.
- Assess emerging technologies to optimize biomarker testing strategies for hematologic malignancies.
Faculty
Ghazal Khan, MBA
Anatomic Pathology Manager, University of Illinois Health
Chicago, Illinois
Faculty Disclosures
Ghazal Khan has no financial relationships to disclose.
Credit Designation Statement
ASCP designates this activity for a maximum of 1.5 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CMLE credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT.
Method of Participation
To complete the activity and receive credit, the participant must participate in the online activity. CMLE certificates will be provided online.
Commercial Support
This activity is supported by a sponsorship from AstraZeneca.